UFP Technologies (UFPT) Stock: Buy, Sell, or Hold?
UFPT - UFP Technologies Inc
$290.11
-1.23 (-0.42%)
▼
5d:
-0.34%
30d:
+1.72%
90d:
+22.82%
HOLD
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 02, 2026
10d
Get Alerted When UFPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: UFPT is fairly valued with market pricing in 4.3% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: UFPT is fairly valued with market pricing in 4.3% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$372.72
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$231.43
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UFPT is currently trading at $290.11, which is considered fair relative to its 30-day fair value range of $282.53 to $299.28. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.4) compared to its historical average (21.5). At these levels, the market is pricing in 4.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, UFPT is in a strong uptrend. The price is currently testing key support at $283.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $355.00 (+22.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, UFPT is in a strong uptrend. The price is currently testing key support at $283.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $355.00 (+22.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$282.53 -
$299.28
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.3%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.4% below Wall St target ($355.00)
- NEUTRAL: Market pricing in 4.3% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (44/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$282.53 -
$299.28
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$283.22
Resistance Level
$301.13
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.44
Wall Street Target
$355.00
(+22.4%)
Revenue Growth (YoY)
15.1%
Earnings Growth (YoY)
21.3%
Profit Margin
11.5%
Valuation Premium vs History
+4.3% premium
PE vs Historical
24.4 vs 21.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.3%
(market-implied from PE analysis)
1-Year Target
$302.58
(+4%)
2-Year Target
$315.60
(+9%)
3-Year Target
$329.17
(+14%)
3-Yr Target (if PE normalizes)
(PE: 24→22)
PE COMPRESSION
$289.62
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.4, Growth: 11.8%)
$405.34
(+40%)
Base:
(SPY PE: 19.9, Growth: 11.8%)
$329.44
(+14%)
Bear:
(PE: 16.9, Growth: 11.8%)
$280.02
(-4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 31.46 | Current EPS (TTM): $9.26
Bull Case
$410.89
(+42%)
Analyst growth 28.2%, PE expands to 34.6
Base Case
$373.53
(+29%)
Market implied 28.2%, PE stable at 31.5
Bear Case
$198.11
(-32%)
Severe decline -20.0%, PE contracts to 26.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 6:29 AM ET
Data refreshes hourly during market hours. Next update: 7:29 AM
Data refreshes hourly during market hours. Next update: 7:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UFPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 59 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 53 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
CATX
Perspective Therapeutics… |
STRONG BUY
14 analysts |
$12 | 60 HOLD |
